GlassScriptPhysician profile
Russell T Simmons
NPI 1720016272
$6,349.37
in general payments reported to CMS, 2019-2025
24 companies · $1,324 in 2025
The $1,324 reported for 2025 was more than what 94% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,033 · 2020: $209 · 2021: $905 · 2022: $895 · 2023: $1,264 · 2024: $719 · 2025: $1,324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,264 · Entertainment: $42.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,264.47 |
| Entertainment | $42.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,700.80 | 2020-2025 | Total30, Precision 1, Dailies Total1 |
| Coopervision INC. | $1,087.69 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Biofinity Contact Lens |
| Topcon Healthcare, INC. | $559.13 | 2021-2025 | |
| Johnson & Johnson Vision Care, INC. | $473.96 | 2019-2025 | Acuvue |
| Glaukos Corporation | $388.06 | 2020-2025 | Photrexa Viscous and Photrexa, Radius Xr |
| Allergan, INC. | $334.36 | 2019-2022 | |
| Maculogix, INC. | $222.81 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $209.08 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $193.12 | 2019-2025 | |
| Rxsight INC | $119.73 | 2023 | Rxsight Injector Handpiece, Rxsight Light Adjustable Lens (Rxlal), Rxsight Light Delivery Device (Ldd) |
| Optos, INC. | $108.08 | 2019-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Lkc Technologies, INC. | $106.15 | 2025 | |
| Abb Con-Cise Optical Group LLC | $102.87 | 2023-2025 | Contact Lens, Spectacle Lenses |
| Biotissue Holdings INC. | $98.36 | 2021-2025 | |
| Bausch & Lomb Americas INC. | $96.19 | 2023-2025 | Xiidra, Miebo, Biotrue One Day |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lombart Brothers, INC. | $93.20 | 2019-2025 | Opd-III |
| Abbvie INC. | $85.17 | 2022 | |
| Sight Sciences, INC. | $76.77 | 2019-2024 | Tearcare System |
| Optovue, INC. | $73.11 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $67.05 | 2023 | Clarus |
| Oyster Point Pharma, INC. | $57.72 | 2023-2024 | Tyrvaya, Ryzumvi |
| Novartis Pharmaceuticals Corporation | $50.31 | 2022-2023 | |
| Lumibird Medical INC. | $23.08 | 2021 | |
| Shire North American Group INC | $22.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Russell Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.